Funds and ETFs Accuray Incorporated

Equities

ARAY

US0043971052

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.185 USD +0.23% Intraday chart for Accuray Incorporated +2.10% -22.79%

ETFs positioned on Accuray Incorporated

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.14% -
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.19 USD
Average target price
8.75 USD
Spread / Average Target
+299.54%
Consensus
  1. Stock Market
  2. Equities
  3. ARAY Stock
  4. Funds and ETFs Accuray Incorporated